What is Global Non-Animal Softgel Capsules Market?
The Global Non-Animal Softgel Capsules Market is a rapidly growing sector in the pharmaceutical and health supplement industry. These capsules are a type of drug delivery system that is made without the use of any animal products, making them suitable for vegetarians and vegans. They are typically made from plant-based materials such as starch or polysaccharides, and are filled with a liquid or semi-solid substance that contains the active ingredient of the medication or supplement. The market for these capsules is expanding due to increasing consumer demand for more ethical and sustainable products. As more people become aware of the environmental and health benefits of plant-based products, the demand for non-animal softgel capsules is expected to continue to rise.
Plant Polysaccharides Softgel Capsules, Starch Softgel Capsules in the Global Non-Animal Softgel Capsules Market:
Plant Polysaccharides Softgel Capsules and Starch Softgel Capsules are two major types of non-animal softgel capsules available in the market. Plant Polysaccharides Softgel Capsules are made from complex carbohydrates found in plants. They are highly beneficial for health as they aid in digestion, lower cholesterol levels, and help in weight management. On the other hand, Starch Softgel Capsules are made from starch, a common food ingredient. These capsules are easy to swallow, digest, and are often used to deliver both pharmaceutical and dietary supplement products. Both these types of capsules are gaining popularity due to their plant-based origin, making them a preferred choice for health-conscious consumers and those following a vegan or vegetarian diet.
Health Supplements, Pharmaceutical, Others in the Global Non-Animal Softgel Capsules Market:
The Global Non-Animal Softgel Capsules Market finds its application in various areas such as health supplements, pharmaceuticals, and others. In the health supplements sector, these capsules are used to encapsulate various vitamins, minerals, and other nutritional supplements. They offer an easy and convenient way for individuals to consume their daily dose of health supplements. In the pharmaceutical sector, non-animal softgel capsules are used to deliver a wide range of medications. They offer several advantages such as improved bioavailability of the drug, ease of swallowing, and enhanced patient compliance. Other applications of these capsules include their use in the cosmetics industry, where they are used to encapsulate various skincare and haircare products.
Global Non-Animal Softgel Capsules Market Outlook:
The future of the Global Non-Animal Softgel Capsules Market looks promising. As of 2023, the market was valued at US$ 553 million and is projected to reach US$ 904.8 million by 2030, growing at a CAGR of 7.2% during the forecast period of 2024 to 2030. Key players in this market include Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, and Robinson Pharma. The largest market for these capsules is the Americas, accounting for about 47% of the global revenue. Europe and the Asia Pacific follow, with market shares of 23% and 20% respectively. This growth is driven by the increasing consumer demand for plant-based products and the growing awareness about the benefits of such products.
| Report Metric | Details |
| Report Name | Non-Animal Softgel Capsules Market |
| Accounted market size in 2023 | US$ 553 million |
| Forecasted market size in 2030 | US$ 904.8 million |
| CAGR | 7.2% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Catalent, Procaps Laboratorios, EuroCaps, Best Formulations, Aenova, Captek, Sirio, Bahrain Pharma, Robinson Pharma, Aland, Fuji Capsule, Sunsho Pharmaceutical, Erkang |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
